| Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619) |
|---|
| 03/04/2003 | US6528510 HIV protease inhibitors |
| 03/04/2003 | US6528508 A bicyclic nitrogen containing heteroaromatic compound useful for inhibiting protein kinase p38 which involved in cell proliferation, cell death and response to extracellular stimuli |
| 03/04/2003 | US6528455 Phenoxy-and thiophenoxy acrylic acid compounds as herbicides |
| 03/03/2003 | WO2002020496A1 2-guanidino-4-aryl-quinazoline |
| 03/03/2003 | CA2421222A1 2-guanidino-4-aryl-quinazoline |
| 02/27/2003 | WO2003016561A2 Method for the production of cna |
| 02/27/2003 | WO2003016317A1 Processes for preparing calcium salt forms of statins |
| 02/27/2003 | WO2003016306A1 Hiv inhibiting pyrimidines derivatives |
| 02/27/2003 | WO2003016292A1 Ultraviolet light absorbers |
| 02/27/2003 | WO2003016288A1 Fxr nr1h4 nuclear receptor binding compounds |
| 02/27/2003 | WO2003016287A2 Process for preparing 1-(carboxymethyl)- and 1-(aminocarbonyl)- pyrimidin-4-one derivatives |
| 02/27/2003 | WO2003015774A1 Compounds effecting glucokinase |
| 02/27/2003 | WO2003015516A1 Compositions and methods for treatment of mitochondrial diseases |
| 02/27/2003 | WO2003000181A3 Dipeptidyl peptidase inhibitors for the treatment of diabetes |
| 02/27/2003 | WO2002096884A3 Substituted benzoylketones as herbicidal agents for use as plant treatment agent |
| 02/27/2003 | WO2002079149A3 Novel cyano-substituted dihydropyrimidine compounds and their use to treat diseases |
| 02/27/2003 | US20030040524 Pyrimidine compounds and methods for making and using the same |
| 02/27/2003 | US20030040521 For controlling and preventing pests |
| 02/27/2003 | CA2454080A1 Ultraviolet light absorbers |
| 02/26/2003 | EP1285914A1 Nr1h4 nuclear receptor binding compounds |
| 02/26/2003 | EP1284968A1 Method of combating undesired plant growth on cereals |
| 02/26/2003 | EP0938483B1 Muscarinic antagonists |
| 02/26/2003 | EP0920431B1 Thienopyrimidines |
| 02/26/2003 | CN1399633A 嘧啶衍生物 Pyrimidine derivatives |
| 02/26/2003 | CN1399632A Pyrimidine derivatives, process for preparing the derivatives and drugs containing the same as active ingredient |
| 02/26/2003 | CN1399561A Conjugate having cleavable linkage for use in liposome |
| 02/26/2003 | CN1399547A Use of INOS inhibitors for treating or preventing myopia |
| 02/26/2003 | CN1102144C Noval pyrimidine derivatives and prepn. processes thereof |
| 02/25/2003 | US6525198 Method for producing 4,6-dichloropyrimidine with sulfur compounds and phosphorus compounds |
| 02/25/2003 | US6525072 Prevention and treatment of cellular disorders such as cancer |
| 02/25/2003 | US6525061 Methods for the solid phase synthesis of 2-amino-4(H)-quinazolinone derivatives |
| 02/25/2003 | US6525060 Triazolo(4,5-d)pyrimidine compounds |
| 02/25/2003 | US6525042 Sulfonyl derivatives |
| 02/25/2003 | US6525036 Compounds and compositions as protease inhibitors |
| 02/25/2003 | US6525025 Controlling apoptosis; cardiovascular disorders; central nervous system disorders |
| 02/25/2003 | US6525020 For drug delivery |
| 02/25/2003 | US6525001 Substituted pyrimidine and pyridine herbicides |
| 02/25/2003 | CA2238331C Cancerous metastasis inhibitors containing uracil derivatives |
| 02/20/2003 | WO2003014296A2 A group of novel anti-cancer compounds with specific structure |
| 02/20/2003 | WO2003014255A1 Fluorescent diketopyrrolopyrrole analogues |
| 02/20/2003 | WO2003014227A1 Novel azo pigments |
| 02/20/2003 | WO2003014092A1 Arylpiperazines and arylpiperidines and their use as metalloproteinase inhibiting agents |
| 02/20/2003 | WO2003014091A1 Pyrimidine derivatives as selective inhibitors of cox-2 |
| 02/20/2003 | WO2003014064A1 Naphthylurea and naphthylacetamide derivatives as vanilloid receptor 1 (vr1) antagonists |
| 02/20/2003 | WO2002068399B1 Aryl carbamate derivatives, preparation and use thereof |
| 02/20/2003 | WO2002067998A3 Devices and methods for the treatment of cancer |
| 02/20/2003 | WO2002065979A3 (diazolo-pyridinyl)-pyrimidines for use in treatment of cns disorders and diabetes |
| 02/20/2003 | WO2002060874A8 Potassium channel inhibitors |
| 02/20/2003 | CA2456144A1 A group of novel anti-cancer compounds with specific structure |
| 02/20/2003 | CA2455754A1 Amine derivatives |
| 02/19/2003 | EP1284261A1 Process for the preparation of 4,6-dihydroxypyrimidine |
| 02/19/2003 | CN1398252A Dehydroamino acids compounds |
| 02/19/2003 | CN1397554A Novel N-benzyl diethylenediamine compound, its prepn. process and medicinal compsns. contg. them |
| 02/19/2003 | CN1101816C Substituted purine derivatives, processes for their prepn. their use, and compsns. comprising them |
| 02/19/2003 | CN1101649C Herbicidal synergistic compsn. and method of controlling weeds |
| 02/18/2003 | WO2002016329A1 Novel phenylalanine derivatives |
| 02/18/2003 | US6521666 Inhibitors of α4 mediated cell adhesion |
| 02/18/2003 | US6521646 Integrin inhibitors |
| 02/18/2003 | US6521632 Method for the treatment or prevention of a disease mediated by the alpha-2B-adrenoceptor |
| 02/18/2003 | US6521627 Insecticidal, acaricidal, nematocidal and fungicidal activities |
| 02/18/2003 | US6521622 Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation |
| 02/18/2003 | US6521620 Suppressing tumors, especially breast cancers; antiproli-ferative agents; arthritis, vascular restenosis, psoriasis and angiogenesis; extremely low cytotoxicity |
| 02/13/2003 | WO2003011872A1 Platelet adp receptor inhibitors |
| 02/13/2003 | WO2003011297A1 N3-substituted 6-anilinopyrimidines and methods to treat gram-positive bacterial and mycoplasmal infections |
| 02/13/2003 | WO2002051388A3 Treatment of inoperable tumors by stereotactic injection of microspheres |
| 02/13/2003 | US20030033089 Substituted quinazolines and analogs and the use thereof |
| 02/13/2003 | US20030032807 Method for the production of 1-amino -3-aryl -uracils |
| 02/13/2003 | US20030032647 Aromatic nitrogen-containing 6-membered cyclic compounds |
| 02/13/2003 | US20030032644 Substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity |
| 02/13/2003 | CA2468925A1 Platelet adp receptor inhibitors |
| 02/12/2003 | EP1283042A1 Aqueous liquid preparation |
| 02/12/2003 | EP1282614A1 Hydroxamic acid derivatives |
| 02/12/2003 | EP1282607A2 Prodrugs of hiv replication inhibiting pyrimidines |
| 02/12/2003 | EP1282606A2 Hiv replication inhibiting pyrimidines and triazines |
| 02/12/2003 | EP1282602A1 Propanoic acid derivatives as integrin receptor antagonists |
| 02/12/2003 | EP1282595A1 Novel phenyl-propargylether derivatives |
| 02/12/2003 | EP1049703B1 N-[2-(5-benzyloxycarbonyl-amino-6-oxo-2-(4-fluorophenyl)-1,6-dihydro-1-pyrimidinyl)acetoxyl]-l-aspartic acid aldehyde as an in vivo inhibitor of interleukin-1beta converting enzyme |
| 02/12/2003 | CN1396158A Process for synthesizing 4,6-dimethoxy-2-methiopyrimidine |
| 02/12/2003 | CN1396157A Process for chemically synthesizing 2,6-bis [(4,6-dimethoxypyrimidine-2-yl) oxy] sodium bezoate |
| 02/12/2003 | CN1101386C Trisubsted phenyl derivitives |
| 02/11/2003 | US6518428 The present invention relates to the area of platinum drugs. In particular, it relates to an improved process for preparing platinum complexes having the general formula (Ia) or (Ib): as defined of herein, |
| 02/11/2003 | US6518426 Pyrimidine derivatives and methods of making and using these derivatives |
| 02/11/2003 | US6518424 Activity as inhibitors of phospholipase A2, and are useful in treating disorders mediated by phospholipase A2 and antiinflammatory agents |
| 02/11/2003 | US6518310 Non-peptidic; inhibits trypsin-like protease, thrombin and embolus formation; anticoagulant |
| 02/11/2003 | US6518306 PDE4 inhibitors particularly in regards to treating allergic and inflammatory diseases |
| 02/11/2003 | US6518283 Squaric acid derivatives |
| 02/11/2003 | US6518277 Disrupting leukocyte function |
| 02/11/2003 | US6518276 Treating a p38 mediated disorders |
| 02/11/2003 | US6518272 HT3 receptor agonists and antagonists; treatment of anxiety, depression, cognitive deficits, and prostate cancer |
| 02/11/2003 | CA2250391C Butadiene derivatives and process for their preparation |
| 02/11/2003 | CA2222851C Keratin fibre oxidation dye composition and dye process using the composition |
| 02/06/2003 | WO2003010153A1 N-alkyl-n-phenylhydroxylamine compounds containing metal chelating groups, their preparation and their therapeutic uses |
| 02/06/2003 | WO2003010152A1 Novel crystal of arylethenesulfonamide derivative and process for producing the same |
| 02/06/2003 | WO2003010151A1 Method for producing 4-methyl pyrimidine |
| 02/06/2003 | WO2003010143A1 Dialkylhydroxybenzoic acid derivatives containing metal chelating groups and their therapeutic uses |
| 02/06/2003 | WO2003010135A1 Novel phenylpropionic acid derivatives |
| 02/06/2003 | WO2002067851A3 Method for treating fibrotic diseases or other indications iiic |
| 02/06/2003 | WO2002061110A3 Nucleic acid derivatives |
| 02/06/2003 | WO2002046172A3 Substituted 1, 3, 5-triazines and pyrimidines as abca-1 elevating compounds against coronary artery disease or atherosclerosis |
| 02/06/2003 | WO2002046141A3 Coumpounds of the formula r1-x-y-z-nr2r3 as abca-1 elevating agents against coronary artery disease or atherosclerosis |